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Abstract: Objectives: The SF-6D is a preference-based measure of health developed to generate utility
values from the SF-36. The aim of this pilot study was to examine the feasibility and acceptability of
using the standard gamble (SG) technique to generate preference-based values for the Arabic version
of SF-6D in a Lebanese population. Methods: The SF-6D was translated into Arabic using forward
and backward translations. Forty-nine states defined by the SF-6D were selected using an orthogonal
design and grouped into seven sets. A gender-occupation stratified sample of 126 Lebanese adults
from the American University of Beirut were recruited to value seven states and the pits using SG.
The sample size is appropriate for a pilot study, but smaller than the sample required for a full
valuation study. Both interviewers and interviewees reported their understanding and effort levels
in the SG tasks. Mean and individual level multivariate regression models were fitted to estimate
preference weights for all SF-6D states. The models were compared with those estimated in the UK.
Results: Interviewers reported few problems in completing SG tasks (0.8% with a lot of problems) and
good respondent understanding (5.6% with little effort and concentration), and 25% of respondents
reported the SG taskwas difficult. A total of 992 SG valuations were useable for econometric modeling.
There was no significant change in the test–retest values from 21 subjects. The mean absolute errors
in the mean and individual level models were 0.036 and 0.050, respectively, both of which were lower
than the UK results. The random effects model adequately predicts the SG values, with the worst
state having a value of 0.322 compared to 0.271 in the UK. Conclusion: This pilot confirmed that it
was feasible and acceptable to generate preference values with the SG method for the Arabic SF-6D
in a Lebanese population. However, further work is needed to extend this to a more representative
population, and to explore why no utility values below zero were observed.
Keywords: Lebanese; SF-6D; preference-based measure; reliability; validation; standard gamble
1. Introduction
The fast growth medical technologies and treatments increasingly requires cost-utility analyses
(CUA) and cost-effectiveness analyses (CEA) to decide on the optimal treatment for every health
condition [1]. Agencies that advise on reimbursement such as the National Institute for Health and
Care Excellence (NICE) commonly require a health-related quality of life (HRQoL) outcomes using
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quality adjusted life years (QALYs) from preference-based measure questionnaires as part of the
decision-making process [2,3]. In order to generate QALYs, there must be a valuation for HRQoL on
the 1–0 full health–death scale through eliciting preferences from the general population by setting full
health to 1 and death to 0 on the scale [4,5].
To date, a large number of preference-based measures exist, including the generic EQ-5D [6],
EQ-5D-5L [7], Healthy Utilities Index 2 (HUI2) andHUI3 [8,9], Assessment of quality of life (AQoL) [10],
Quality of Well-Being scale (QWB) [11], and the SF-6D [12], in addition there are a growing number of
condition-specific preference-based measures [13]. All of these preference-based measures of health
have been valued in their countries of origin, and there is increased interest in obtaining values from
other countries, for example [14–22], among many others.
The SF-36 [23,24] served as the base for the SF-6D used in several valuation studies. Previously,
a scoring algorithm for the SF-6D has been derived from the general UK population using the standard
gamble (SG) technique [12]. This has been used to elicit values for several countries, including
China [19], Japan [20], Hong Kong [21], Brazil [22], Portugal [23], and Australia [24]. There were
significant differences between UK values and the other countries, which suggested cultural differences
in values. It is likely that significant differences in the preferences for different health states may also
exist in a Lebanese population relative to other populations. To the best of our knowledge, there have
been no studies in any Middle Eastern country to elicit valuations for the SF-6D health states.
However, a few steps must be taken before applying the SF-6D to the Lebanese population.
First, it is imperative to confirm the ability to generate a Lebanese preference-based valuation for the
multi-dimensional SF-6D health states using preference elicitation tasks. Second, it is compulsory to
check if a valuation of the representative population can be used to produce a scoring algorithm to
generate utility values for all possible SF-6D states. Since most studies using SG have been conducted
on Western populations, little is known about its feasibility, validity, and reliability in Middle Eastern
populations including the Lebanese population.
Thus, the aim of this pilot study is to examine the feasibility and acceptability of valuing the Arabic
SF-6D in a Lebanese population using the SG method. If the results are positive, preference-based
measures of health such as the SF-6D could be valued by the Lebanese population to generate a
definitive value set for Lebanon. This may enable the inclusion of the Lebanese population in global
and multi-ethnic pharmacoeconomic evaluation studies.
In the following sections, we describe the methods of the SF-6D valuation survey and the data
collection process. The modeling of the valuation data is also outlined. Then, we present our findings
in Section 3 and finish with a discussion of the results, their implications, and briefly consider the
possible future studies.
2. Methods
2.1. The SF-6D
The SF-6D is derived from the SF-36. It is composed of six health dimensions, including physical
functioning, role limitation, social functioning, bodily pain, mental health and vitality, each having
between four and six levels [12]. Defining a health state requires choosing a level from each dimension,
hence creating 18,000 possible combinations. Since every possible health state is described by six digits,
from 1 to 6, the perfect health state (full health) is indicated by the combination 111,111, whereas the
“pits” (worst health state) is indicated by 645,655.
2.2. Subjects
Lebanese adults aged between 18 and 70 years old were recruited at the American University
of Beirut (AUB), stratified based on gender (male/female) and on occupation (faculty/staff and
employees/students). Potential participants were contacted by phone and/or email to schedule an
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interview session. However, those who could not be reached after two attempts and those unwilling to
participate were excluded from the study.
As this was a feasibility study, a formal sample size calculation was not undertaken. Previous
experiences with the SF-6D have shown that 15 observations per health state are adequate to estimate
a new model [19]. Hence, a total of 126 people, 21 in each of the six gender-occupation groups,
were interviewed out of 170 initially contacted potential participants, thus giving a response rate of
74%. Each one of the seven sets of health states (see below for further details) was valued by three
respondents from every group (gender-occupation) for a total of 18 valuations per health state. In order
to assess the reliability of the questionnaire, a random sample of 21 participants across all six groups
was interviewed a second time 2–4 weeks after the initial interview.
2.3. Data Collection Procedure
An Arabic version of the original SF-6D Health Survey was developed by forward and backward
translations using professional translators. The latter has been done in collaboration with a team in
Egypt and the United Arab Emirates (UAE) [25], for which the English equivalence has been approved
by the developers Brazier and Kharroubi. Given that the SF-6D is known to be an elaborated descriptive
system, with 18,000 possible outcomes, a sample of 49 health states was generated using the orthoplan
procedure in SPSS (SPSS Inc., Chicago, IL, USA). For the sake of future comparison, the 49 health
states chosen were the same used in the feasibility study of Chinese SF-6D valuation by Lam et al. [19],
and which included every level of every dimension at least once. Those states were then distributed
over seven sets, each containing seven health states each represented by a six-digit number, where each
digit denotes a level from the SF-6D dimensions in the following sequence: Physical functioning (PF),
role limitation (RL), social functioning (SF), pain, mental health (MH), and vitality (VIT). In addition,
each respondent valued “pits” (worst health state).
Interview sessions took place between late January 2019 and early March 2019. The interview
officially started after briefly explaining the study to the participants and obtaining their written
consent. The sets of health states were used in a rotational manner to reduce the interviewer learning
effect. The interview session followed a certain sequence of events, where the subject was asked to:
(1) Answer the Arabic version of the SF-6D; (2) rank eight health states (the set of seven health states
and the “pits” state); (3) value the seven health states and the pits ranked using the SG technique used
by Brazier et al. [12] in a random order to reduce the bias effect that could arise from the order of the
states; (4) provide some information about their demographics; and (5) fill in an evaluation survey
about the interview. The study has been ethically approved by the Institutional Review Board (IRB) at
the AUB.
The interview protocol was analogous to the one applied in the UK valuation study [12]. The aim
was to allow fair comparison across the two valuation studies. Each respondent was asked to rank and
value eight health states using theMcMaster ‘ping pong’ variant of the SG [26]. The SG technique asked
the respondents to value seven of the eight SF-6D health states against the perfect health state and
the “pits” state. Respondents were then asked in the eighth SG question to value “pits”. Depending
on whether they thought this state was better or worse than death they would be asked to consider
one of the following choices: (i) The certain prospect of being in the “pits” state and the uncertain
prospect of perfect health or immediate death; or (ii) the certain prospect of death and the uncertain
prospect of perfect health or the “pits” state. The chances of the best outcome occurring is varied
until the respondent is indifferent between the certain and uncertain prospects. The negative of the
indifference probability of the best outcome is used to value states worse than death, having the effect
of bounding negative values at −1 [27]. Then, the other seven health states were chained onto the zero
to one scale, where 0 is given to states perceived equivalent to being dead, and 1 is given to perfect
health [12]. Having valued the “pits” state (P), the seven intermediate SF-6D health state valuations
(SG) are adjusted using the formula SG + (1 − SG)*P, where the best SF-6D state is 1 and death 0, for use
in the modelling.
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The interview material was in Arabic and the interviews were conducted by a trained interviewer,
who after the interview reported their views on the understanding, effort, and concentration of the
subject. The respondent also reported how they found the SG tasks.
2.4. Patient and Public Involvement
Patients or the public were not involved in the design, or conduct, or reporting, or dissemination
of the research.
2.5. Data Analysis and Outcome Measures
This study evaluated different aspects of the Arabic SF-6D. First, the feasibility of the health survey
was assessed by (1) the completion rate of the interviews; (2) percentage of states with useable values;
(3) interview’s duration; (4) respondent understanding, effort, and concentration as reported by the
interviewer; and (5) respondents own rating of how they found the SG tasks including their effort,
frustration, and boredom.
Data were considered unusable if the results obtained from the respondents met any one of the
following three conditions: (1) All health states had the same valuation; (2) less than two health states
were valued; and (3) pits state was not valued. The valuation of the pits state was essential in order to
chain the respondents’ health state on the full health-death scale, where full health had a value of 1,
dead had a value of zero, and any negative value was bounded by −1. These adjusted SG values form
the dependent variable (y) in the models discussed below.
The test–retest reliability of the survey was assessed by analyzing the results obtained from
the 21 re-interviewed subjects using the mean difference between test and retest results (statistical
significance tested by paired t-test), and intraclass correlation (ICC) calculated using the two-way
mixed effects model where respondents’ effects were considered as random and interviewers’ effects
were fixed. As for the validity of applying standard modelling techniques, this was assessed by
fitting the models to Lebanese SG data and comparing predictive ability and consistency of the model
coefficients with the results of the UK SF-6D.
To understand the size and potential importance of differences between the UK value set and this
Lebanese population we also compared the distribution of values, mean health state values for the
39 common states, and their intra class correlation. We also compared the ranking of the coefficients
from the models.
2.6. Modelling
The modelling methods followed the same methods as the UK study [12]. Models have been
estimated at the aggregate level; that is, the explanatory variables were used to estimate the mean
value given to each of the states by the respondents that valued them (the mean level model). Models
have also been estimated at the individual level that takes into account the variation both within and
between respondents using a random effects (RE) model.
The general model for health state valuations is:
yi j = g
(
β′xi j + θ
′ri j + δ
′zi j
)
+ εi j (1)
where i = 1, 2, . . . , nj represents individual health state values and j = 1, 2, . . . , m, yi j represents
individual respondents, g is a function specifying the appropriate form, and εi j is an error term, whose
properties depend on the assumptions of the model [12]. The dependent variable, yi j, is the adjusted
SG score for health state i valued by respondent j, x is a vector of binary dummy variables for each λ of
dimension δ of the descriptive system, where the best level of each dimension represents the baseline
for that dimension. For example, x32 denotes dimension δ = 3 (social functioning), level λ = 2 (health
limits social activities a little of the time). For any given health state, xδλ is defined as:
xδλ = 1 if, for this state, dimension δ is at level λ
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xδλ = 0 if, for this state, dimension δ is not at level λ
In all, there are 25 of these terms, hence, for a simple linear model, the intercept represents
state 111,111, and summing the coefficients of the ‘on’ dummies derives the value of all other states.
The r term is a vector of terms to account for interactions between the levels of different attributes.
However, given the small sample size, we did not look at interaction terms here. Finally, z is a vector
of respondent level characteristics such as age, sex, or socio-economic factors.
Mean level models were estimated using the ordinary least squares (OLS) and random and fixed
effects models were also estimated using generalized least square (GLS) and maximum likelihood
estimation in order to take into account repeated observations for each individual [12]. For the random
effects (RE) model the error term, εi j, is subdivided as follows:
u j + ei j (2)
where u j represents the individual random effect, assumed to be random across individual respondents,
and ei j represents the random error term for the health state valuation i of individual j.
The models were evaluated considering the following criteria: (1) Inconsistencies in the estimated
coefficients, as the coefficients of dummy variables representing each level of SF-6D are expected to
be negative and increasing in absolute size as the level of severity increases (amongst coefficients
with statistical significance); (2) adjusted R2, mean absolute error, and the proportion of predictions
outside 0.05 (% absolute error > 0.05) and 0.10 (% absolute error > 0.10) ranges on either side of the
observed value. Predictions were further tested in terms of bias (t-test). Analysis was performed using
SPSS version 24.0 (SPSS Inc., Chicago, IL, USA) (Statistical Package for Social Sciences. Available
from: http://www.spss.com/software/) and R 2.9.1 (R Development Core Team, Vienna, Austria) (R:
A language and environment for statistical computing. R Foundation for Statistical Computing.
Available from: www.R-project.org).
3. Results
3.1. Participants
One hundred and twenty-six participants were recruited from AUB and belonged to either
one of the three following categories: (1) Faculty, (2) staff, and (3) students. The mean age of the
participants was 32.45 years, which is very close to the mean age of the Lebanese general adult
population (31 years) [28]. The gender distribution (male/female) of the subjects (50.8%/49.2%) was
in line with that of the general population (50.2%/49.8%). However, 88.7% of the participants hold a
degree or above, which is very far from the descriptive of the general population (13.8%), and 71.3%
have a total household income higher than 2200 USD. The discrepancy in educational level and the
high total household income are due to our sample population being recruited from an educational
institution. As for the housing, a large proportion of respondents (41.9%) live with their parents, since
one third of our data was collected from students. The marital status is consistent with that of the
general population, since 63.7% of the Lebanese are listed as single. More information about the
sociodemographic characteristics of the interviewed population is available in Table 1.
3.2. Feasibility and Acceptability
The 126 recruited participants completed all parts of the questionnaire, thus providing a 100%
completion rate. Two subjects out of the 126 participants gave the same valuation for all eight valued
health states, including the pits, and were excluded from the data analysis. No respondents were
excluded for failing to value two or more health states or for failing to value the pits state. The mean
time for completing the whole interview was 26.98 min (SD 8.62, ranged from 11 to 70).
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Table 1. Sociodemographic characteristics of respondents.
Characteristic
Total Sample
(N = 124)
Test–Retest Subjects
(N = 21)
Lebanese General Adult Population
(N = 6,100,075) *
Mean age in years (SD) 32.45 (12.39) 29.31 (8.19) 31 **
Male/female (%) 50.8/49.2 42.9/57.1 50.2/49.8 ***
Educational level (%)
Intermediate or secondary 14 (11.3) 2 (9.5) 36.8 ****
Degree and above 110 (88.7) 19 (90.5) 13.4%
Marital status (%)
Single 79 (63.7) 18 (85.7) 56% *****
Married 43 (34.7) 3 (14.3) 39%
Widowed/Divorced 2 (1.6) - 5%
Housing type (%)
Private 48 (38.7) 6 (28.6) -
Rental 24(19.4) 2 (9.5) -
Living with parents/roommates 52 (41.9) 13 (61.9) -
Monthly household income (%)
Less than 2,399,000 LL~1599.33 USD 20 (16.4) 5 (23.8) -
2,400,000–3,299,000 LL~1600–2199.33 USD 15 (12.3) 3 (14.3) -
Greater than 3,300,000 LL~2200 USD 89 (71.3) 13 (61.9) -
* CIA Factbook, 2019; ** Mouhtadi et al., 2018; *** World Bank, 2016; **** CAS, 2004; ***** CAS, 2007.
Table 2 shows the interviewer and respondent evaluations on the process of the ranking and SG
exercises. According to interviewers’ evaluations, the vast majority of respondents had no problems
or only some problems performing and concentrating on the ranking task (over 99% and 94.4%,
respectively) and SG (over 99% and 93.5%). In regard to the respondents’ evaluations, almost all
of the respondents (92.7%) mentioned trying their best in answering the questionnaire. Half of the
respondents (50.0%) said that they considered three or more dimensions in the SG decision indicating
the majority were not lexicographic in their preferences. None of respondents found the task very
difficult and none thought the quality of their answers was poor. The process was acceptable to most
subjects with 75.0% evaluating the ranking and SG tasks as easy or neutral and 79.0% reporting no
degree of irritation or boredom during any of the ranking or SG exercises.
Table 2. Feasibility and acceptability of the SG and ranking for the SF-6D descriptive system.
Variables
Interviewer Rating of Interviewee Participation (n = 126)
Problem in Performing
Task (%)
Effort and
Concentration (%)
Problem in Performing
Task (%)
Effort and
Concentration (%)
None
(47.6)
Some
(51.6)
A Lot
(0.8)
Great
(59.7)
Some
(34.7)
Little
(5.6)
None
(58.1)
Some
(41.1)
A Lot
(0.8)
Great
(27.4)
Some
(66.1)
Little
(6.5)
Interviewee
self-evaluation
Ranking SG
Challenge level of task
Easy (37.1%) 21.0 16.1 0.0 20.2 12.9 4.0 23.4 13.7 0.0 7.3 25.8 4.0
Neutral (37.9%) 13.7 23.4 0.8 24.2 12.9 0.8 20.2 16.9 0.8 10.5 25.8 1.6
Difficult (25.0%) 12.9 12.1 0.0 15.3 8.9 0.8 14.5 10.5 0.0 9.7 14.5 0.8
Tried best to answer
Yes (92.7) 45.2 46.8 0.8 56.5 31.5 4.8 55.6 36.3 0.8 25.8 61.3 5.6
No (7.3) 2.4 4.8 0.0 3.2 3.2 0.8 2.4 4.8 0.0 1.6 4.8 0.8
Number of dimensions
considered in SG
None (13.7) 7.3 6.5 0.0 8.1 5.6 0.0 7.3 6.5 0.0 4.0 8.9 0.8
One (2.4) 0.8 1.6 0.0 0.8 1.6 0.0 1.6 0.8 0.0 0.0 2.4 0.0
Two (33.9) 16.9 16.9 0.0 22.6 10.5 0.8 22.6 11.3 0.0 6.5 26.6 0.8
≥Three (50.0) 22.6 26.6 0.8 28.2 16.9 4.8 26.6 22.6 0.8 16.9 28.2 4.8
Quality of answers
Very good (33.9%) 16.1 17.7 0.0 19.4 12.1 2.4 20.2 13.7 0.0 8.1 22.6 3.2
Good (51.6%) 25.0 25.8 0.8 31.5 17.7 2.4 29.8 21.8 0.0 15.3 33.9 2.4
Average (14.5%) 6.5 8.1 0.0 8.9 4.8 0.8 8.1 5.6 0.8 4.0 9.7 0.8
Felt bored or irritated
Yes (21.0) 1.6 2.4 0.0 1.6 2.4 1.6 0.0 1.6 2.4 2.4 1.6 0.0
No (79.0) 46.0 49.2 0.8 46.0 57.3 33.1 5.6 56.5 38.7 25.0 64.5 6.5
SG: Standard gamble; SF-6D: Short form 6 dimensions.
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3.3. Test–Retest Reliability
Three to four weeks after the first interview, a random pool of 21 respondents were selected for a
repeat interview, in order to check the reliability of the questionnaire. The ranking of the best health
state card as the top was consistent in both interviews for all 21 respondents. On the other hand,
six (28.6%) respondents reversed the order of the pits and severe cards between the first and second
interviews (two ranked a severe card the lowest in the first interview but the pits health state lowest
in the second interview; and four ranked the pits health state the lowest in the first interview but a
severe card the lowest in the second interview). There were 168 paired health state values for the
assessment of the test–retest reliability. The mean difference of SG valuations between baseline and
post-test was 0.0092 (95% CI −0.02, 0.04), which was not statistically significant by the paired t-test
(t = 0.549, p = 0.583). The ICC of SG valuations between baseline and post-test was 0.667 (95% CI 0.55,
0.75), which was almost in line with the standard of 0.7 for group comparison [29].
3.4. SF-6D Valuation
Each of the 126 subjects valued seven health states from the SF-6D in addition to “pits”, resulting
in a total of 1008 health state valuations (882 observations for the health states and 126 for “pits”).
The number of observations was evenly distributed across the 49 health states selected by orthoplan
using SPSS. All 126 participants were able to value the seven health states in addition to “pits”, however,
two of them provided the same valuation for all eight health states (including “pits”). Therefore,
in total, we had 992 (98.4%) useable observations (868 observations for the health states and 124
for “pits”). Table 3 shows the mean with SD, median, minimum, maximum values and the number
of usable values of the 49 SF-6D health states valued in the sample and “pits”. These results were
compared to the valuations from the UK study. However, it is important to note that some health states
valued in this pilot study were not part of the original UK study (health states 124,125, 135,312, 212,145,
221,452, 334,521, 425,131, 432,621, 523,551, 534,113, and 611,221), and hence their appropriate cells in
Table 3 were left empty.
It can be seen that the observed values for the “pits” state (645,655) in this pilot ranged between
0.100 and 0.750, with amean value of 0.322 (±0.190), whereas in the UK study, its values ranged between
−0.980 and 0.980 with a mean of 0.213 (±0.428). As for the best health state (211,111), its observed
valuations ranged between 0.820 and 0.960, with a mean value of 0.890 (±0.042), whereas in the UK
study they ranged between 0.190 and 1.000 with a mean value of 0.778 (±0.276). For an example of a
moderate state, the observed mean value for state 142,154 is 0.791 (±0.159), with a range of 0.370–0.920,
whereas in the UK study, its mean value is 0.513 (±0.378), with a range of 0.280–0.950. For 36 out of the
39 common states the mean health state values from the Lebanese sample exceeded the equivalent UK
values by an average of 0.135 (±0.123). The overall level of agreement between UK and Lebanese mean
health state values was not high with an ICC of 0.172 (95% CI −0.087, 0.438).
The left skewness in elicited utility values at the individual level is shown in the histogram for the
992 individual health states values in Figure 1. There are no negative values observed in the Lebanese
sample. However, a large proportion of the values were above 0.9 (19%), as also observed in the UK
(23%). There were no utility values at 1.0, which indicates that all participants were willing to risk a
worse health state to have a chance for a better state.
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Table 3. Descriptive statistics for the 50 SF-6D health state valuations comparing Lebanon and the UK.
Lebanon United Kingdom
Health State Mean S.D. Minimum Maximum Median N Mean S.D. Minimum Maximum Median N
111,621 0.824 0.114 0.440 0.950 0.850 18 0.620 0.414 −0.060 0.990 0.845 10
113,411 0.854 0.098 0.550 0.960 0.885 18 0.597 0.363 −0.140 0.980 0.610 12
115,653 0.730 0.152 0.370 0.920 0.760 18 0.581 0.273 0.100 0.980 0.590 8
121,212 0.842 0.102 0.460 0.910 0.855 18 0.783 0.235 0.280 0.970 0.783 7
122,233 0.869 0.044 0.760 0.940 0.880 17 0.827 0.233 0.140 1.000 0.905 14
122,425 0.758 0.173 0.370 0.930 0.820 17 0.657 0.357 0.100 1.000 0.855 10
124,125 0.848 0.132 0.370 0.960 0.890 18 - - - - - -
131,542 0.828 0.102 0.520 0.950 0.880 18 0.424 0.414 −0.660 0.960 0.450 17
132,524 0.763 0.168 0.370 0.940 0.820 18 0.580 0.352 0.000 1.000 0.615 8
133,132 0.858 0.046 0.760 0.940 0.855 18 0.569 0.364 0.000 1.000 0.670 11
135,312 0.756 0.176 0.370 0.910 0.820 18 - - - - - -
142,154 0.791 0.159 0.370 0.920 0.850 17 0.513 0.378 0.280 0.950 0.310 10
144,341 0.742 0.194 0.190 0.920 0.820 17 0.727 0.247 0.120 0.990 0.825 30
211,111 0.890 0.042 0.820 0.960 0.900 18 0.778 0.276 0.190 1.000 0.905 10
212,145 0.785 0.152 0.370 0.950 0.830 18 - - - - - -
213,323 0.783 0.156 0.360 0.940 0.820 18 0.743 0.255 0.120 0.980 0.790 12
221,452 0.824 0.079 0.640 0.940 0.820 18 - - - - - -
224,612 0.646 0.170 0.360 0.900 0.640 18 0.540 0.380 −0.240 0.880 0.670 9
232,111 0.858 0.062 0.700 0.940 0.880 17 0.759 0.359 0.000 1.000 0.960 9
235,224 0.767 0.164 0.280 0.910 0.835 17 0.468 0.307 0.100 0.990 0.430 11
241,531 0.785 0.179 0.190 0.920 0.845 18 0.753 0.237 0.280 0.990 0.880 17
312,332 0.864 0.047 0.720 0.950 0.880 18 0.778 0.267 0.190 1.000 0.910 12
315,515 0.698 0.195 0.330 0.940 0.745 18 0.559 0.254 0.190 0.970 0.550 15
321,122 0.858 0.062 0.720 0.940 0.850 18 0.757 0.248 0.190 0.990 0.850 17
323,644 0.571 0.200 0.190 0.900 0.575 18 0.397 0.309 0.100 0.990 0.290 10
332,411 0.844 0.062 0.720 0.940 0.860 17 0.770 0.269 0.190 1.000 0.835 12
334,251 0.734 0.149 0.370 0.900 0.800 17 - - - - - -
341,123 0.831 0.170 0.190 0.960 0.880 18 0.757 0.313 0.100 0.990 0.920 10
412,152 0.793 0.129 0.460 0.950 0.850 18 0.501 0.284 0.100 0.930 0.590 10
414,522 0.755 0.172 0.330 0.940 0.810 18 0.541 0.390 −0.010 1.000 0.570 11
421,314 0.811 0.090 0.630 0.940 0.820 18 0.713 0.341 0.100 1.000 0.845 12
425,131 0.658 0.188 0.360 0.900 0.715 18 - - - - - -
431,443 0.824 0.104 0.460 0.920 0.850 17 0.613 0.384 0.000 1.000 0.805 12
432,621 0.743 0.150 0.370 0.900 0.820 17 - - - - - -
443,215 0.731 0.242 0.190 0.920 0.840 18 0.673 0.345 −0.060 1.000 0.805 12
511,114 0.858 0.059 0.720 0.950 0.880 18 0.604 0.316 0.100 1.000 0.590 13
512,242 0.603 0.230 0.190 0.940 0.550 18 0.705 0.188 0.250 0.910 0.750 11
522,321 0.777 0.163 0.280 0.940 0.840 18 0.675 0.317 0.120 0.990 0.700 11
523,551 0.607 0.231 0.190 0.900 0.678 18 - - - - - -
531,635 0.786 0.118 0.510 0.920 0.820 17 0.439 0.950 −0.850 0.950 0.450 14
534,113 0.723 0.191 0.280 0.930 0.800 17 - - - - - -
545,422 0.700 0.248 0.190 0.920 0.825 18 0.604 0.325 0.100 0.990 0.620 9
611,221 0.821 0.087 0.580 0.950 0.830 18 - - - - - -
614,434 0.561 0.265 0.190 0.940 0.530 18 0.652 0.292 0.110 0.960 0.710 13
622,513 0.707 0.171 0.360 0.920 0.720 18 0.567 0.368 0.000 1.000 0.640 13
625,141 0.510 0.236 0.190 0.900 0.505 18 0.703 0.312 0.140 0.990 0.860 10
631,355 0.741 0.152 0.370 0.920 0.760 17 0.657 0.300 0.100 0.980 0.700 15
633,122 0.714 0.253 0.190 0.930 0.800 17 0.466 0.353 0.000 0.910 0.470 8
642,612 0.685 0.245 0.190 0.920 0.775 18 0.484 0.397 −0.280 1.000 0.675 18
645,655 0.322 0.190 0.100 0.750 0.300 124 0.213 0.428 −0.980 0.980 0.050 622
SD: Standard deviation; RE: Random effect.

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Figure 1. Histogram and descriptive statistics for the adjusted health state valuations (n = 992).
Int. J. Environ. Res. Public Health 2020, 17, 1037 9 of 15
3.5. Modelling
The models used for the analysis were random effect (RE) models at the individual level and
the ordinary least square (OLS) model at the aggregate (using the mean values of the 50 valued
health states) level. In both models, the constant was restricted to unity. The results of the obtained
beta coefficients estimated for each level in every dimension, model predictive ability (MAE and
number of absolute errors greater than 0.05 or 0.10), and the number of inconsistent preference-based
coefficients are presented in Table 4. Our results are compared to those of the UK valuation study
by Brazier et al. [12]. Coefficients found to be significantly different from zero at α > 0.05 are marked
in bold. For the RE model, 17 out of the 25 parameters were significant. However, at α > 0.10,
an additional parameter (VIT4) became significant, meaning a total of 18 out of 25 parameters were
significant. The parameter estimates for physical functioning and social functioning were very similar
to those of the UK. For instance, the coefficient for PF6 was −0.173 compared to 0.160 in the UK,
and that of SF5 was −0.116 to −0.109. However, there were marked differences in the coefficients
for pain across all levels with level 6 scoring −0.093 in the Lebanon compared to −0.178 in the UK.
There were smaller but nonetheless potentially important differences in the coefficients for the other
dimensions. The order of the decrements in the Lebanese model resulted in a ranking of PF with
the largest, followed by RL, SF, Pain, MH, and VIT. This contrasts with the UK that also had PF first,
but this was followed by Pain, MH, SF, VIT, and RL.
Table 4. Mean and individual level models for Lebanon and UK.
Parameter
RE Mean
Lebanon UK Lebanon UK
PF2 −0.061 −0.058 −0.056 −0.060
PF3 −0.056 −0.051 −0.058 −0.020
PF4 −0.069 −0.088 −0.071 −0.060
PF5 −0.106 −0.061 −0.106 −0.063
PF6 −0.173 −0.160 −0.168 −0.131
RL2 −0.057 −0.056 −0.049 −0.057
RL3 −0.039 −0.076 −0.004 −0.068
RL4 −0.119 −0.078 −0.049 −0.066
SF2 −0.050 −0.066 −0.063 −0.071
SF3 −0.050 −0.048 −0.106 −0.084
SF4 −0.072 −0.066 −0.122 −0.093
SF5 −0.116 −0.109 −0.162 −0.105
PAIN2 −0.013 −0.042 −0.032 −0.048
PAIN3 0.005 −0.046 −0.016 −0.034
PAIN4 −0.021 −0.055 −0.034 −0.070
PAIN5 −0.018 −0.103 −0.062 −0.107
PAIN6 −0.093 −0.178 −0.102 −0.181
MH2 −0.009 −0.043 −0.011 −0.057
MH3 −0.033 −0.055 −0.022 −0.051
MH4 −0.082 −0.115 −0.098 −0.121
MH5 −0.083 −0.125 −0.064 −0.140
VIT2 0.005 −0.040 −0.009 −0.094
VIT3 −0.010 −0.030 0.006 −0.069
VIT4 −0.025 −0.040 −0.042 −0.069
VIT5 −0.055 −0.087 −0.024 −0.106
N 992 3518 50 249
Adjusted R2 N/A N/A 0.950 0.508
Inconsistencies 2 4 2 5
MAE 0.050 0.078 0.036 0.074
AE > 0.05 20 122 14 118
AE > 0.10 4 59 1 52
RE: Random effect; PF: Physical functioning; RL: Role limitation; SF: Social functioning; PAIN: Pain; MH: Mental
health; VIT: Vitality; R2: R-squared; MAE: Mean absolute error; AE: Absolute error. Estimates shown in bold are
significant at α < 0.05.
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All coefficients in the UK study were negative in the RE model [12]. In our study, we had
two parameters showing positive coefficients (PAIN3 and VIT2), both of which are insignificant.
The MAE in the RE model for Lebanon was better than that of UK; 0.050 compared to 0.078 in the UK.
Two significant inconsistent coefficients were found, where the estimated effect decreases from level 2
to level 3 for the physical functioning (i.e., PF2 (−0.061) vs. PF3 (−0.056)) and level 2 to level 3 for the
role limitations (i.e., RL2 (−0.057) vs. RL3 (−0.039)) in the RE model. However, the UK model had four
such inconsistencies.
As for the OLS mean model, the UK study observed 23 significant parameters while we observed
14 out of 25 parameters to be significant at α > 0.05 and at α > 0.10, an additional parameter (RL4)
became significant, for a total of 15 out of 25 parameters. This smaller number may have been a result
of a much smaller sample size. The UK mean model had two positive coefficients (PF3 and PAIN2),
whereas in the Lebanese mean model VIT3 was positive. The MAE for Lebanon was smaller than that
of UK, 0.036 and 0.074, respectively, as is the case with the RE model. Again, there were important
differences in the parameter coefficients estimated from the OLS mean model for Lebanon compared to
those of the UK. This time the ordering of decrements was PF followed by SF, Pain, MH, RL, and VIT.
The UK mean model places pain at the top, followed by MH, PF, VIT, SF, and RL. This suggests there
may be major differences in the relative weights for these dimensions.
Overall the models on the Lebanese valuation data had good performance. Two significant
inconsistent coefficients were found, where the estimated effect decreases from level 2 to level 3 for
the role limitations (i.e., RL2 (−0.049) vs. RL3 (−0.004)) and level 4 to level 5 for the mental health
(i.e., MH4 (−0.098) vs. MH5 (−0.064)) in the OLS mean model. In comparison, the UK model had five
such inconsistencies. The adjusted R2 of the OLS mean model for Lebanon was almost double that of
UK, 0.950 and 0.508, respectively. Figure 2 presents the actual and predicted valuations for the RE
model for the 49 valued health states and the pits. The RE model predicts the observed health state
values quite well and in contrast to the UK model, does not seem to suffer from the tendency to over
predict at low health state values (i.e., poor health states).
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Figure 2. Actual and predicted health state valuations for the RE model.
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Finally, there is a key finding from the models that is worth mentioning. Namely, for the Lebanese
sample, there is almost no discrimination in preference-based coefficients as a function of severity for
either the pain or vitality dimensions. For both of these dimensions, coefficients for all but the most
severe level of each are not statistically significant (and having small magnitude), and even the most
severe level of vitality is not statistically significant for the aggregate model. In the results above, we
pointed to the fact that there were fewer inconsistencies in magnitude of coefficients across dimension
severity levels for the Lebanese sample than for the UK sample in the models, but we only focused on
statistically significant coefficients in this count. Whether we use the actual values of non-significant
coefficients, or if we just consider their values to be 0, there are many more inconsistencies for the
Lebanese sample. We consider this finding in more detail in Section 4.
4. Discussion
Health state valuation is a relatively new research area in the Middle East, with two studies
investigating the validity and reliability of the Arabic version of the EQ-5D-3L in Jordan and Saudi
Arabia [30,31] and only one study focused on testing the feasibility of eliciting EQ-5D-5L values from a
general public sample in the UAE [32]. The Arabic translation of EQ-5D-3L appeared to be valid and
reliable in measuring the quality of life in Jordanian and Saudi people. In addition, results suggested
that it is feasible to generate meaningful health-state values in the UAE and most of the respondents
stated that their religious beliefs influenced their responses to the valuation tasks.
The results of this pilot study supported the feasibility and acceptability of using the SGmethod to
generate health state utility values for the SF-6D in Lebanon, to generate QALYs, and hence to conduct
cost utility analysis of health care interventions. The Lebanese SF-6D preference weights estimated
here offer a method for producing utility values from existing SF-36 data. We believe that using SF-6D
health state preference values from the Lebanese population to conduct cost-effectiveness studies in
Lebanon is more appropriate than using values obtained in other countries. The results from our study
sample were positive in a sense that preference-based measures of health such as the SF-6D could be
adapted nationally to the Lebanese population who can then be included in global and multi-ethnic
pharmacoeconomic studies.
After excluding unusable data from two participants, we had a completion rate of 98.4% which is
much higher than that obtained in the UK where 36.8% of respondents were excluded from the data
analysis [12]. This may be because we had a well-educated sample and only had two well-trained
interviewers who made sure that respondents valued every health state. The Lebanese values were
higher than those of the UK for 36 out of the 39 comparable states. Furthermore, the ordering of the
dimension coefficients indicates a higher weight is given to PF, RL, and SF compared to pain and MH
than the UK population. This indicates important possible differences in health preferences between
the two cultures.
The mean health states for the 49 valued states were broadly consistent with the severity of the
health state. This means that the scoring of the health state decreased with the increasing number of
dimensions with severe levels in that state i.e., the misery score, which is the sum of all the severity
levels of each dimension (e.g., themisery score for state 511,114= 5+ 1+ 1+ 1+ 1+ 4= 13). For instance,
health state 511,114 had a mean value of 0.858 while state 512,242 had a value of 0.603.
The performance of the Lebanese models was compared to that of the UK model, and they both
had good comparative performance relative to the UK models with MAE of 0.036 compared to 0.074
and adjusted R2 of 0.950 compared to 0.508 for the OLS mean model; and MAE of 0.050 and 0.078,
respectively, for the RE model. These results support the validity of the preference-based valuation by
SG of the SF-6D in a Lebanese population for the generation of scoring algorithms applicable to the
Lebanese population.
There were two significant inconsistencies in the estimated significant coefficients, where the
estimated effect decreases from level 2 to level 3 for the physical functioning (i.e., PF2 (−0.061) vs. PF3
(−0.056)) and level 2 to level 3 for the role limitations (i.e., RL2 (−0.057) vs. RL3 (−0.039)) in the REmodel.
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However, the UK model had four such inconsistencies. Two more significant inconsistent coefficients
were found, where the estimated effect decreases from level 2 to level 3 for the role limitations (i.e., RL2
(−0.049) vs. RL3 (−0.004)) and level 4 to level 5 for the mental health (i.e., MH4 (−0.098) vs. MH5
(−0.064)) in the OLS mean model, whereas the UK model had five such inconsistencies. These results
will further support the validity and quality of the data from the Lebanese population. These results
are promising given the relatively smaller size of the Lebanese sample compared to the UK.
The models show that two of the six dimensions, pain and vitality, have small and insignificant
coefficients for all severity levels with the exception of the worst level (s), and for vitality there are
no significant coefficients for the mean level model. While it would be expected that values on some
dimensions may differ across cultures (e.g., one would expect that the importance of social functioning
could be different across different cultures, we would expect pain severity in particular to impact on
health state preferences. This raises the question whether this finding would be observed in a larger
sample of respondents, and whether this finding would be observed using a valuation study including
a larger number of health states. However, if this result is replicated in a larger study this raises the
question as to whether pain and vitality are relevant for inclusion in a preference-based measure
in Lebanon if the Lebanese population do not state that milder and moderate problems with these
dimensions impact on their utility. This is an important issue and is the subject of further work.
Limitations of this study include the use of a small sample of 126 people. This is much smaller than
the UK study which involved 611 people, so it may limit the generalizability of the preference values
found. More sophisticated models could be tested with data obtained from a larger sample of health
states (Kharroubi et al. [33–39]). However, this study aims at testing the feasibility and acceptability of
the use of SG to value the SF-6D in Lebanon, in order to proceed with a larger valuation study involving
a larger number of participants. Further research is underway to assess this. In particular, ongoing
valuation study for a sample of 249 health states defined by the SF-6D by a nationally representative
sample of 577 participants matched with the national proportionate of gender and age category from
all Lebanese governorates using standard gamble has preliminary results that are very promising.
Upon completion, this study would be the first valuation study of the SF-6D in the Middle East,
and therefore, neighbouring countries would benefit from this value set until similar studies are
conducted in the region.
Whilst previous studies have found a relatively low number of utility values below zero elicited
using the SG technique (for example the UK valuation of SF-6D using SG found 7% of responses were
below zero [12]), the lack of utility values below zero is surprising. One possibility is that this was due
to the small sample size, but a small number of utility values might still be expected with the sample
size analysed here. There are many potential reasons why no values below zero have been observed,
including attitudes to risk, characteristics of the particular survey sample, and the perceived severity
of the states. There could be cultural or religious reasons why participants are not willing to say a
health state is worse than being dead. For these reasons the interviewers may have been reluctant to
move to the task for states worse than dead. Future research is recommended to explore this further
since this is the first valuation study conducted in the Lebanese population.
An additional concern is around the understanding and concentration of study participants.
Whilst the study participants report that they tried their best to answer (92.7%) and few felt bored
or irritated (21.0%) only 50% of participants considered three or more of the dimensions in making
their choices, and 25.0% of participants found the level of the task difficult. The level of difficulty of
the task is to be expected given the complexity of the task. The fact that 50% of people considered
only two or fewer dimensions when making their choices may reflect a simplifying heuristic observed
in discrete choice experiments too whereby participants may have focused on a small number of
dimensions to make the tasks easier to complete. This question is rarely asked in valuation surveys and
so it is not possible to say whether this is unusual. However, the interviewer reporting of participant
effort and concentration and problems in performing the tasks indicates that only a small number of
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participants had a lot of problems with the SG task (0.8%), or were reported to have had little effort
and concentration (6.5%).
Our study sample was recruited from AUB, hence, the majority of our respondents were well
educated (88.7% hold a degree or above). This may lead to a concern about whether SG is feasible
and acceptable for use with people with low education levels, because SG requires the respondent to
think in abstract terms of probability. Furthermore, the small number of health states valued could
impact on the accuracy of the econometric modelling. Overall, the generated SF-6D preference-based
coefficients from this pilot study should not be regarded as necessarily representative of the general
population of Lebanon. Further studies with a larger and more representative sample from the general
population are required to generate a definitive SF-6D value set for the Lebanese population.
5. Conclusions
This study has demonstrated that generating a scoring algorithm for the SF-6D for the Lebanese
population using the SG technique is overall feasible and acceptable. The performance of the
econometric models derived from the Lebanese data compared favorably to the UK study, particularly
given the smaller sample size. Given the overall encouraging nature of the results, this suggests
that health state utility elicitation using SG could be used in Lebanon and other Arab populations in
the MENA region. The large differences observed in the parameter estimates coefficients between
the UK and Lebanon suggest it is important to have a local value set. However, further research is
recommended to determine whether SG is feasible and acceptable in a sample in Lebanon with lower
education levels, and to further generate a definitive value set for Lebanon using a representative
sample of the general population.
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